Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/143557
Full metadata record
DC FieldValueLanguage
dc.creatorCouto, M
dc.creatorVasconcelos, DP
dc.creatorSousa, DM
dc.creatorSousa, B
dc.creatorConceição, F
dc.creatorNeto, E
dc.creatorLamghari, M
dc.creatorAlves, CJ
dc.date.accessioned2022-08-29T14:35:48Z-
dc.date.available2022-08-29T14:35:48Z-
dc.date.issued2020
dc.identifier.issn2296-8016
dc.identifier.urihttps://hdl.handle.net/10216/143557-
dc.description.abstractJoint replacement surgery is the gold-standard therapeutic approach to treat patients with end-stage hip and knee arthritis, providing pain relief and joint function recovery. Despite the improvements in implant design and surgical techniques, revisions after total joint replacement are expected to grow. The periprosthetic inflammation, featured by the sustained inflammatory response to the implant debris, elicits the activation of osteoclasts and consequent periprosthetic osteolysis (PPOL), ultimately leading to implant aseptic loosening, which is the most common cause of long-term implant failure. There are currently no effective strategies to control periprosthetic inflammation, and long-term implant survival remains a major challenge in orthopedics. A broad knowledge of the mechanisms underlying the biological response to implant debris would support the development of novel and effective pharmacological strategies to manage PPOL and promote implant lifespan. In this review, a detailed description of the cellular and the molecular mechanisms underlying the biological response to implant debris is provided, highlighting the most recent findings. Furthermore, we reviewed novel therapeutic strategies that are being investigated to prevent inflammatory periprosthetic osteolysis.
dc.description.sponsorshipThis work was financed by the project NORTE-01-0145- FEDER-000012, supported by the Norte Portugal Regional Operational Program (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). DS was a recipient of Fundação para a Ciência e a Tecnologia (FCT) post-doctoral fellowship (SFRH/BPD/115341/2016). FC was a recipient of FCT Ph.D. fellowship (SFRH/BD/128771/2017).
dc.language.isoeng
dc.publisherFrontiers Media
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBPD%2F115341%2F2016/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F128771%2F2017/PT
dc.relation.ispartofFrontiers in Materials, vol.7:274
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectaseptic loosening
dc.subjectimplant wear particles
dc.subjectorthopedic implants
dc.subjectosteolysis
dc.subjectperiprosthetic inflammation
dc.titleThe Mechanisms Underlying the Biological Response to Wear Debris in Periprosthetic Inflammation
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3389/fmats.2020.00274
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fmats.2020.00274/full
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3389-fmats.2020.00274.pdf833.12 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons